Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 28, 2025
Reporting Period: The filing references financial information for the three and twelve months ended December 31, 2024, and includes forward-looking statements for 2024 and beyond.
Key Financial Metrics
The Form 8-K text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within Exhibit 99.1, which is a press release dated January 28, 2025, incorporated by reference. The filing text states that this information is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Material Changes
The filing text does not explicitly detail material changes versus prior periods. It directs readers to the attached press release (Exhibit 99.1) for the results of operations and financial condition for the periods ended December 31, 2024.
Guidance, Outlook, and Risks
- Outlook: The filing includes forward-looking statements relating to 2024 and beyond, as presented in the referenced press release.
- Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K form; they are likely addressed in the full press release or the company's periodic reports.
- Unusual Items: None identified in the filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) to obtain actual revenue, profit, and cash flow figures for the three and twelve months ended December 31, 2024.
- Verify the specific forward-looking statements regarding 2024 and beyond contained in the press release.
- Note that the financial data in this filing is furnished under Item 2.02 and is not subject to the liabilities of Section 18 of the Exchange Act.
- Confirm the company's status as a non-emerging growth company based on the unchecked box in the filing.